ABT-737 (Inhibitor for Bcl-2 family)

MBS355714-1g

ABT-737 (Inhibitor for Bcl-2 family)

2754.12 €

MBS355714-500mg

ABT-737 (Inhibitor for Bcl-2 family)

1727.75 €

MBS355714-5x1g

ABT-737 (Inhibitor for Bcl-2 family)

11347.62 €

2253-5

BCl-2 Inhibitor, ABT-199

709.8 €

HY-50907S

ABT-737-d8

ABT 737-d8 is the deuterium labeled ABT-737. ABT-737, a BH3 mimetic, is a potent Bcl-2, Bcl-xL and Bcl-w inhibitor with EC50s of 30.3 nM, 78.7 nM, and 197.8 nM, respectively. ABT-737 induces the disruption of the BCL-2/BAX complex and BAK-dependent but BIM-independent activation of the intrinsic apoptotic pathway. ABT-737 induces autophagy and has the potential for acute myeloid leukemia (AML) research[1][2][3].

2467.64 €

MBS6057143-1mg

ABT 737-d8

956.38 €